Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -53,916 | -162,013 | -171,855 | -133,978 | -37,938 |
| Depreciation Amortization | 12,927 | 14,275 | 14,508 | 14,951 | 16,551 |
| Accounts receivable | -1,378 | 3,576 | -867 | 20,164 | -20,301 |
| Accounts payable and accrued liabilities | -6,359 | 6,199 | -122 | -3,384 | 4,274 |
| Other Working Capital | -46,425 | 90,585 | 1,606 | -14,959 | -64,657 |
| Other Operating Activity | -46,855 | 8,851 | 26,974 | 3,464 | 46,200 |
| Operating Cash Flow | $-142,006 | $-38,527 | $-129,756 | $-113,742 | $-55,871 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -268,068 | N/A | -102,230 | N/A |
| PPE Investments | -9,976 | -4,091 | -10,583 | -9,722 | -31,457 |
| Purchase Of Investment | -297,251 | N/A | -164,662 | N/A | -443,122 |
| Sale Of Investment | 269,656 | 322,068 | 313,265 | N/A | 491,292 |
| Other Investing Activity | 0 | 0 | -25,000 | 0 | 0 |
| Investing Cash Flow | $-37,571 | $49,909 | $113,020 | $-111,952 | $16,713 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 77,940 | -1,978 | N/A |
| Debt Repayment | -3,536 | -2,992 | -174,844 | N/A | -1,356 |
| Common Stock Issued | 163,520 | 8,208 | 4,117 | 224,313 | 8,891 |
| Other Financing Activity | -7,000 | -3,000 | 119,588 | 0 | 0 |
| Financing Cash Flow | $152,984 | $2,216 | $26,801 | $222,335 | $7,535 |
| Exchange Rate Effect | -109 | 32 | 60 | 916 | -219 |
| Beginning Cash Position | 39,067 | 25,437 | 15,312 | 17,755 | 49,597 |
| End Cash Position | 12,365 | 39,067 | 25,437 | 15,312 | 17,755 |
| Net Cash Flow | $-26,702 | $13,630 | $10,125 | $-2,443 | $-31,842 |
| Free Cash Flow | |||||
| Operating Cash Flow | -142,006 | -38,527 | -129,756 | -113,742 | -55,871 |
| Capital Expenditure | -9,976 | -4,091 | -10,583 | -9,722 | -31,457 |
| Free Cash Flow | -151,982 | -42,618 | -140,339 | -123,464 | -87,328 |